BioNTech produces 10 times more antibodies than China’s Sinovac: study

Hong Kong’s pro-Beijing leaders, including Chief Executive Carrie Lam, mostly opted to receive China’s Sinovac

People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing data on different jabs’ effectiveness.

But they warned that “the difference in concentrations of neutralising antibodies identified in our study could translate into substantial differences in vaccine effectiveness”.

Read Next

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button